New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors (Englisch)
In:
Current Pharmaceutical Design
;
19
, 4
;
734-744
;
2013
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors
-
Weitere Titelangaben:CPD
-
Beteiligte:
-
Erschienen in:Current Pharmaceutical Design ; 19, 4 ; 734-744
-
Verlag:
- Neue Suche nach: Bentham Science Publishers Ltd.
-
Erscheinungsdatum:01.12.2013
-
Format / Umfang:11 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 19, Ausgabe 4
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 529
-
Editorial (Hot Topic: Cross-Talking Metabolism and Epigenetics in Anti-Cancer Drug Design)Del Rio, Alberto et al. | 2013
- 532
-
Anti-cancer Drug Development: Computational Strategies to Identify and Target Proteins Involved in Cancer MetabolismLora Mak, Sonia Liggi, Lu Tan, Kanthida Kusonmano, Judith M. Rollinger, Alexios Koutsoukas, Robert C. Glen, Johannes Kirchmair et al. | 2013
- 578
-
Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery PerspectivesFederico Andreoli, Armenio Jorge Moura Barbosa, Marco Daniele Parenti, Alberto Del Rio et al. | 2013
- 614
-
Rejuvenating Sirtuins: The Rise of a New Family of Cancer Drug TargetsSantina Bruzzone, Marco Daniele Parenti, Alessia Grozio, Alberto Ballestrero, Inga Bauer, Alberto Del Rio, Alessio Nencioni et al. | 2013
- 624
-
ADP-Ribosylated Proteins as Old and New Drug Targets for Anticancer Therapy: The Example of ARF6Nadia Dani, Armenio Jorge Moura Barbosa, Alberto Del Rio, Maria Di Girolamo et al. | 2013
- 634
-
Wnt/beta-Catenin Signaling and Small Molecule InhibitorsAndrey Voronkov, Stefan Krauss et al. | 2013
- 665
-
Glycogen Synthase Kinase 3 as an Anticancer Drug Target: Novel Experimental Findings and Trends in the Design of InhibitorsDmitry I. Osolodkin, Vladimir A. Palyulin, Nikolay S. Zefirov et al. | 2013
- 680
-
Genetic and Epigenetic Regulation of Phosphoinositide 3-kinase IsoformsChanse Fyffe, Richard Buus, Marco Falasca et al. | 2013
- 687
-
Fibroblast Growth Factor Receptor InhibitorsSuneel Kumar B.V.S, Lakshmi Narasu, Rambabu Gundla, Raveendra Dayam, Sarma J.A.R.P et al. | 2013
- 702
-
Immunoproteasome in Cancer and Neuropathologies: A New Therapeutic Target?Stefano Salvioli, Miriam Capri, Agostino Baruzzi, Alberto Del Rio, Claudio Franceschi, Michele Mishto, Elena Bellavista, Federico Andreoli, Marco Daniele Parenti, Morena Martucci, Aurelia Santoro, et al. | 2013
- 719
-
Regulation and Function of DNA and Histone MethylationsKarin Johanna Ferrari, Diego Pasini et al. | 2013
- 734
-
New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase InhibitorsMichele Cea, Antonia Cagnetta, Marco Gobbi, Franco Patrone, Paul G. Richardson, Teru Hideshima, Kenneth C. Anderson et al. | 2013
- 745
-
microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and CancerFrancesca De Santa, Ilaria Iosue, Alberto Del Rio, Francesco Fazi et al. | 2013
- 765
-
Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and EpigeneticsPaolo Garagnani, Chiara Pirazzini, Claudio Franceschi et al. | 2013
- 779
-
Exploring Patterns of Epigenetic Information with Data Mining TechniquesVanessa Aguiar-Pulido, Jose A. Seoane, Marcos Gestal, Julian Dorado et al. | 2013
- 790
-
Accessing Cancer Metabolic Pathways by the Use of Microarray TechnologyMartin Koch, Michael Wiese et al. | 2013
- 806
-
Corrigendum| 2013